MCM
AYTU icon

MAI Capital Management’s AYTU BioPharma AYTU Stock Holding History

MAI Capital Management’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,575
Closed -$9.76K – 2308
2026
Q1 		$9.76K Hold
3,575
– – ﹤0.01% 3190
2025
Q4 		$9.29K Hold
3,575
– – ﹤0.01% 2888
2025
Q3 		$6.72K Hold
3,575
– – ﹤0.01% 2906
2025
Q2 		$7.79K Hold
3,575
– – ﹤0.01% 2862
2025
Q1 		$4.29K Hold
3,575
– – ﹤0.01% 2769
2024
Q4 		$6.08K Buy
+3,575
New +$6.53K ﹤0.01% 2708

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Crown Advisors Management Larkspur, California $182M AUM 103.97% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

MAI Capital Management's AYTU Position: Q2 2026 in Review

MAI Capital Management sold out of AYTU BioPharma (AYTU) in Q2 2026, closing a stake of 3,575 shares — an estimated $9.76K sold.

MAI Capital Management first reported a position in AYTU in Q4 2024 and held it in 6 quarters. The position peaked at $9.76K in Q1 2026. 38 funds tracked by Wall St. Rank hold AYTU as of Q2 2026.

  • MAI Capital Management reported no remaining AYTU BioPharma position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 3,575 AYTU BioPharma shares in Q2 2026, an estimated $9.76K.
  • MAI Capital Management first reported a position in AYTU BioPharma in Q4 2024 and held it in 6 quarters.
  • MAI Capital Management's AYTU BioPharma position peaked at $9.76K in Q1 2026.
  • 38 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.